IRIDEX IRIX Files 8-K Furnishing Q2 2025 Financial Results

Rhea-AI Filing Summary

IRIDEX Corporation disclosed a press release reporting its financial results for the second fiscal quarter ended June 28, 2025, and furnished that release as Exhibit 99.1 to this Form 8-K. The company specifies that the press release is furnished and therefore is not deemed "filed" for purposes of Section 18 of the Exchange Act, meaning it is incorporated by reference only as expressly stated. The filing confirms the company’s common stock trades on the Nasdaq Capital Market under the symbol IRIX and is signed by Chief Executive Officer Patrick Mercer.

Insights

Securities Analyst

TL;DR: The Form 8-K furnishes Q2 results but includes no financial figures here, so the filing itself is neutral until the press release is reviewed.

The 8-K notifies investors that a press release covering the second fiscal quarter results was furnished as Exhibit 99.1. Because the filing contains no operating metrics, revenue, earnings, or guidance, it carries no immediate quantifiable impact in isolation. Investors must review the furnished press release for material financial data before assessing changes to the company’s operating or valuation outlook.

Corporate Governance Expert

TL;DR: Routine disclosure practice; furnishing the press release (not filing) limits Section 18 liability and clarifies incorporation by reference.

The document follows common disclosure protocol by furnishing a press release as an exhibit and explicitly stating it is not "filed" for Section 18 purposes. This distinction is procedural but important legally: it limits the circumstances under which the content is treated as filed within subsequent securities filings. The 8-K also documents the authorized signature by the CEO, consistent with regulatory execution requirements.

false000100604500010060452025-08-122025-08-12

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	August 12, 2025
(Date of Report (date of earliest event reported)
IRIDEX CORPORATION
(Exact name of registrant as specified in its charter)
Delaware		000-27598	77-0210467
(State or other jurisdiction of incorporation or organization)		(Commission File Number)	(I.R.S. Employer Identification Number)
1212 Terra Bella Avenue Mountain View, California 94043
(Address of principal executive offices, including zip code)
(650) 940-4700
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of Class		Trading Symbol		Name of Exchange on Which Registered
Common Stock, par value $0.01 per share		IRIX		Nasdaq Capital Market

Item 2.02. Results of Operations and Financial Condition.

On August 12, 2025, IRIDEX Corporation issued a press release discussing its financial results for its second fiscal quarter ended June 28, 2025. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press Release dated August 12, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

-2-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934,as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			IRIDEX CORPORATION
	By:		/s/PATRICK MERCER
			Patrick Mercer
			Chief Executive Officer
Date: August 12, 2025

-3-

FAQ

What did IRIDEX (IRIX) disclose in this Form 8-K?

IRIDEX disclosed it furnished a press release reporting financial results for its second fiscal quarter ended June 28, 2025, filed as Exhibit 99.1.

Is the press release considered 'filed' with the SEC?

No; the company states the press release is furnished and is not deemed "filed" for purposes of Section 18 of the Exchange Act.

Where is IRIDEX's common stock listed and under what symbol?

IRIDEX's common stock is listed on the Nasdaq Capital Market under the symbol IRIX.

Which exhibits were attached to the Form 8-K?

Exhibit 99.1 is the press release and Exhibit 104 is the cover page interactive data file (Inline XBRL).

Who signed the Form 8-K for IRIDEX?

The Form 8-K is signed on behalf of the registrant by Patrick Mercer, Chief Executive Officer.